FDA Inspection 1106594 — Bunge North America OVC West
The FDA completed an inspection of Bunge North America OVC West on August 27, 2019 in Emporia, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 27, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Emporia, KS (United States)